H

Hanmi Pharm.
A128940

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
₩3.63T
EV
₩4.04T
Shares Outstanding
12.68M
Beta
0.64

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
₩356153.85
P/E 2025E
22.57x
P/Revenue 2025E
2.24x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Hanmi Pharm. Co., Ltd.

gainify

H

Hanmi Pharm. Co., Ltd.

A128940

Hanmi Pharm. Co., Ltd., a biopharmaceutical company, engages in the manufacture and sale of pharmaceutical products in South Korea, China, Japan, the United States, and internationally. It focuses on research areas with high unmet medical needs, including obesity, met...

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Park, Jae-Hyun

Employees

2,330

IPO Date

2010-07-30

Headquarters

214 Muha-ro, Paltan-myeon, Hwaseong-si, Gyeonggi-do, 18536, South Korea

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

COMPANY

Pricing

Dashboard

About Us

Contact Us

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.